1) Transcatheter arterial chemoembolization
肝动脉栓塞化疗
1.
Combination of radiofrequency ablation with cooled-tip electrodes and transcatheter arterial chemoembolization for treatment of unresectable liver cancer;
冷循环射频消融联合肝动脉栓塞化疗治疗不宜手术切除的肝癌
2.
Objective: To evaluate the clinical effectiveness of herbal medication 960 mixture combined with transcatheter arterial chemoembolization (TACE) in the treatment of advanced liver cancer.
目的 :研究中药 96 0合剂内服配合肝动脉栓塞化疗 (TACE)治疗晚期肝癌的临床疗效。
3.
Objective:To analysis the influence of p-glycoprotein and NF-КB expression after transcatheter arterial chemoembolization(TACE) in hepatocellular carcinoma (HCC).
目的:分析TACE(肝动脉栓塞化疗)对肝癌细胞多药耐药基因表达产物P-GP(P糖蛋白)、核转录因子NF-КB的表达影响,探讨P-GP和肝癌预后的关系,从耐药基因角度评价TACE对肝癌治疗的价值。
2) TACE
[英]['teisi:] [美]['tesi]
肝动脉栓塞化疗
1.
objective: To evaluate the clinical significance of selective portal vein chemotherapy (SPVC) and percutaneous ethanol injection therapy (PEIT) guided by color Doppler ultrasonography (CDU) after transhepatic arterial chemo-embolization (TACE).
目的 :探讨彩超引导下经皮经肝选择性门静脉化疗 ( SPVC)结合瘤内无水酒精注射疗法 ( PEIT)联合肝动脉栓塞化疗 ( TACE)治疗中晚期肝癌的临床应用价值。
2.
Objective To explore the value of removing portal vein tumor thrombus (PVTT) and TACE in improving the outcome of resection for primary liver cancer with PVTT.
目的 探讨肝癌合并门静脉癌栓的手术疗效 ,评价术中门静脉癌栓取出术和术后辅助肝动脉栓塞化疗对提高肝癌术后生存率的影响。
3) transcatheter hepatic artery chemoembolization
肝动脉栓塞化疗
1.
Study of unresectable hepatocarcinoma by transcatheter hepatic artery chemoembolization combined with percutaneous radiofrequency ablation;
肝动脉栓塞化疗联合经皮射频消融治疗肝癌
4) Transcatheter arterial chemoembolization
肝动脉化疗栓塞
1.
Therapeutic effect of transcatheter arterial chemoembolization combined with percutaneous ethanol injection for treatment of moderete and late stage liver cancer;
肝动脉化疗栓塞联合无水乙醇注射治疗中晚期肝癌的近期疗效观察
2.
Development in radiotherapy combined with transcatheter arterial chemoembolization for primary liver cancer.;
放疗联合肝动脉化疗栓塞治疗肝癌的研究进展
3.
Effect of transcatheter arterial chemoembolization on HBV DNA level in primary liver cancer patients
肝动脉化疗栓塞对原发性肝癌患者HBV DNA水平的影响
5) hepatic arterial chemoembolization
肝动脉化疗栓塞
1.
Analysis on electrolytes and liver function indexes of patients after undergoing hepatic arterial chemoembolization;
肝动脉化疗栓塞后电解质和肝功能指标的变化
2.
To observe the short-term effect of Aidi injection and hepatic arterial chemoembolization (TACE) for primary hepatic carcinoma (PHC).
观察艾迪注射液合肝动脉化疗栓塞(TACE)治疗晚期原发性肝癌32例的近期疗效,对照组病人用TACE术治疗,治疗组用TACE术加艾迪注射液治疗,结果:治疗组近期疗效比对照组明显提高,说明艾迪注射液合TACE可有效治疗晚期原发性肝癌,提高患者生活质量,降低毒副作用。
3.
Transcather arterial chemoembolization (TACE), also called hepatic arterial chemoembolization (HACE), is considered a secure, effective and repeatable first selecting conventional therapy for the inoperable hepatama.
经导管动脉内化疗栓塞术(transcather arterial chemoembolization, TACE)又称肝动脉化疗栓塞治疗,是目前公认为对不能手术切除的原发性肝癌的安全、有效、可反复的首选常规治疗方法,它近期疗效显著,可使肿瘤缩小,症状缓解,并有效杀灭肿瘤细胞,在一定时间内控制肿瘤的生长,延长患者生存时间。
补充资料：妇科肿瘤灌注化疗栓塞术
妇科肿瘤灌注化疗栓塞术
介入放射学技术。妇科恶性肿瘤的介入治疗方法之一。经动脉插管置髂内动脉或肿瘤供血动脉分支，行选择性或超选择性插管、造影，并观察血供分布情况后注入化疗药的治疗方法。一般采用一次性大剂量灌注化疗，然后再栓塞治疗。也可采用所谓夹心栓塞疗法，即先用明胶海绵颗粒(2mm×2mm)作髂内动脉小分支及肿瘤末梢血管栓塞，再灌注化疗药，最后用明胶海绵栓塞髂内动脉分支的近端，以暂时阻断血流。将明胶海绵在抗癌药内浸泡后栓入肿瘤供血动脉，可同样达到上述目的。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条